Utilisation : Ce produit est destiné uniquement à la recherche.
Toutes les informations sur les produits présentes sur ce site sont fournies à titre éducatif uniquement. Toute forme d’introduction dans le corps humain ou animal est strictement interdite par la loi. Ce produit doit être manipulé uniquement par des professionnels agréés et qualifiés. Il ne s’agit pas d’un médicament, d’un aliment ou d’un cosmétique et il ne doit pas être présenté, utilisé ou étiqueté comme tel.
Prostamax, 20mg
Pendant notre changement d’emballage, vous pouvez recevoir des produits avec l’ancienne ou la nouvelle étiquette. La formulation, la pureté et la qualité restent exactement les mêmes, selon nos standards.
- Carte de crédit
- Virement bancaire (SEPA instantané)
- Virement bancaire (ACH)
- Wise
- Revolut
- Zelle
- Remitly
- Western Union
- Chime
- Autres
-25% sur tout – jusqu’au 31 octobre
25% sur les prix habituels, en remplacement des autres soldes. Cumulable uniquement avec la remise crypto.
Expédition le jour même pour les commandes aux États-Unis passées avant 12 h EST.
Voir la politique de livraison →Chaque lot est testé pour sa pureté, sa puissance et sa qualité.
Voir les résultats d’analyse →Prostamax is a short peptide bioregulator investigated for its interactions with peptide-mediated regulatory pathways and molecular signaling systems. Experimental studies have examined its activity in transcription-associated processes, chromatin-interaction models, peptide–DNA binding investigations, and signal transduction research.
Its low-molecular-weight peptide structure makes it a useful tool for studies of peptide bioregulator pharmacology, molecular regulatory mechanisms, transcription-associated signaling pathways, and comparative investigations of short regulatory peptide compounds.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
3D Molecular Structure
Drag to rotate · scroll to zoom| Chemical Formula | C20H33N5O9 |
|---|---|
| Synonyms | SCHEMBL6660498 |
| Molar Mass | 487.5 g/mol |
| PubChem CID | 9848296 |
| Total Compound Content | 20 mg per vial |
| Shelf Life | 36 months |
Every batch is independently lab tested for identity, purity and potency. View our lab testing program →
What is the proposed mechanism of action of peptide bioregulators such as Prostamax?
A proposed mechanism for short peptide bioregulators involves interactions with chromatin-associated regulatory systems and transcription-related molecular pathways.
Experimental investigations have examined whether short peptide sequences can interact with DNA-protein complexes, influence chromatin architecture, and modulate transcription-associated processes through peptide-mediated molecular recognition mechanisms.
This proposed mode of action remains an active area of investigation and continues to be explored through studies of peptide–DNA interactions, chromatin dynamics, and transcriptional regulation.
How does Prostamax relate to other short peptide bioregulators?
Prostamax belongs to a broader class of short peptide bioregulators that share common characteristics, including low molecular weight, short amino acid sequences, and proposed activity within molecular regulatory systems. Comparative investigations frequently examine differences in peptide sequence composition, chromatin-interaction profiles, signaling pathway modulation, and transcription-associated effects to better understand structure-activity relationships across this class of compounds.
What experimental evidence has been reported for Prostamax's molecular activity?
Published investigations have reported effects on transcription-associated processes, peptide-mediated regulatory pathways, chromatin-interaction models, and molecular signaling mechanisms. These findings have contributed to ongoing research into short peptide bioregulator pharmacology and the proposed role of regulatory peptides in modulating molecular signaling networks.
As with many compounds in this category, further mechanistic investigation and independent validation remain important areas of continued research.
